Trial Profile
A Phase II Evaluation of Tirapazamine (NSC 130181, IND 46,525) in Combination With Cisplatin in Recurrent Platinum Sensitive Ovarian or Primary Peritoneal Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Nov 2015
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Tirapazamine (Primary)
- Indications Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 03 Sep 2005 New trial record.